この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2018/7/251 分で読めます
Facilitating Competition and Innovation in the Biological Products Marketplace; Public Hearing; Request for Comments
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA or the Agency) is announcing a public hearing on FDA's approach to enhancing competition and innovation in the biological products marketplace, including by facilitating greater availability of biosimilar and interchangeable products.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →